欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SK/H/0207/002
药品名称Maysiglu 50 mg filmom obalené tablety
活性成分
    • SITAGLIPTIN 50.0 mg
剂型Film-coated tablet
上市许可持有人KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Slovenia
参考成员国 - 产品名称Slovakia (SK)
Maysiglu 50 mg filmom obalené tablety
互认成员国 - 产品名称
    • Poland (PL)
      Maysiglu
    • Latvia (LV)
      Maysiglu 50 mg apvalkotās tabletes
    • Lithuania (LT)
      Maysiglu 50 mg plėvele dengtos tabletės
    • Estonia (EE)
      MAYSIGLU
    • Hungary (HU)
      Maysiglu 25-50-100 mg filmtabletta
    • Bulgaria (BG)
      Maysiglu
    • Czechia (CZ)
      Maysiglu
    • Romania (RO)
    • Slovenia (SI)
      Maysiglu 50 mg filmsko obložene tablete
    • Croatia (HR)
许可日期2019/12/23
最近更新日期2022/11/03
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase